Viridian Therapeutics

Aug 07, 2025

•

Jun 30, 2025

Viridian Therapeutics Q2 2025 Earnings Report

Estimated Revenue:$47K

-42.4% YoY

Estimated EPS:-$0.98

15.5% YoY

Viridian Therapeutics

Unlock previous datapoints

Upgrade

Viridian Therapeutics

Unlock previous datapoints

Upgrade

Loading...

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Viridian Therapeutics

Key Statistics

Market Cap

$3.15B

P/E Ratio

-7.64

Sector

N/A

Industry

N/A

52-Week High

$33.7

52-Week Low

$11

Products

Get in Touch

Resources

Viridian Therapeutics

Viridian Therapeutics Q2 2025 Earnings Report

Viridian Therapeutics

Viridian Therapeutics

Historical Earnings Impact

Avg. Return Before/After Earnings

Company Overview

Key Statistics